General Information of Drug Off-Target (DOT) (ID: OTFDI7JP)

DOT Name Small integral membrane protein 19 (SMIM19)
Gene Name SMIM19
UniProt ID
SMI19_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Pfam ID
PF15117
Sequence
MAGGYGVMGDDGSIDYTVHEAWNEATNVYLIVILVSFGLFMYAKRNKRRIMRIFSVPPTE
ETLSEPNFYDTISKIRLRQQLEMYSISRKYDYQQPQNQADSVQLSLE

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
13 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate decreases the expression of Small integral membrane protein 19 (SMIM19). [1]
Ciclosporin DMAZJFX Approved Ciclosporin decreases the expression of Small integral membrane protein 19 (SMIM19). [2]
Tretinoin DM49DUI Approved Tretinoin decreases the expression of Small integral membrane protein 19 (SMIM19). [3]
Doxorubicin DMVP5YE Approved Doxorubicin increases the expression of Small integral membrane protein 19 (SMIM19). [4]
Cupric Sulfate DMP0NFQ Approved Cupric Sulfate decreases the expression of Small integral membrane protein 19 (SMIM19). [5]
Estradiol DMUNTE3 Approved Estradiol decreases the expression of Small integral membrane protein 19 (SMIM19). [6]
Quercetin DM3NC4M Approved Quercetin decreases the expression of Small integral membrane protein 19 (SMIM19). [7]
Hydrogen peroxide DM1NG5W Approved Hydrogen peroxide affects the expression of Small integral membrane protein 19 (SMIM19). [8]
Menadione DMSJDTY Approved Menadione affects the expression of Small integral membrane protein 19 (SMIM19). [8]
PMID28460551-Compound-2 DM4DOUB Patented PMID28460551-Compound-2 decreases the expression of Small integral membrane protein 19 (SMIM19). [10]
Formaldehyde DM7Q6M0 Investigative Formaldehyde increases the expression of Small integral membrane protein 19 (SMIM19). [11]
Milchsaure DM462BT Investigative Milchsaure decreases the expression of Small integral membrane protein 19 (SMIM19). [12]
Resorcinol DMM37C0 Investigative Resorcinol decreases the expression of Small integral membrane protein 19 (SMIM19). [13]
------------------------------------------------------------------------------------
⏷ Show the Full List of 13 Drug(s)
1 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene affects the methylation of Small integral membrane protein 19 (SMIM19). [9]
------------------------------------------------------------------------------------

References

1 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
2 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
3 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
4 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
5 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
6 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
7 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
8 Time series analysis of oxidative stress response patterns in HepG2: a toxicogenomics approach. Toxicology. 2013 Apr 5;306:24-34.
9 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
10 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
11 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
12 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
13 A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo. Carcinogenesis. 2012 Jul;33(7):1421-9.